Amicus Therapeutics Announces First Quarter 2024 Financial Results and Corporate Updates
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
Amicus Therapeutics (FOLD) PT Lowered to $13 at BofA Securities
May 10, 2024 5:27 AM EDTBofA Securities analyst Tazeen Ahmad lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $13.00 (from $14.00) while maintaining a Buy rating.
The analyst comments "FOLD reported 1Q Pombiliti+Opfolda (P&O) sales of $11mn and provided FY24 sales guidance of $62-67mn.... More
Amicus Therapeutics (FOLD) PT Lowered to $19 at Morgan Stanley
May 9, 2024 12:03 PM EDTMorgan Stanley analyst Jeffrey Hung lowered the price target on Amicus Therapeutics (NASDAQ: FOLD) to $19.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "1Q earnings were in line with Street expectations for Galafold and below on Pombiliti + Opfolda (P+O). The company... More
